Evidence map›Paper›PMID 22357848›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2012

Rescue of dopamine transporter function in hypoinsulinemic rats by a D2 receptor-ERK-dependent mechanism.

W Anthony Owens, Jason M Williams, Christine Saunders, Malcolm J Avison, Aurelio Galli, Lynette C Daws

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Frontiers in molecular neuroscience · 2020
    Article
  7. Review
  8. Article
  9. Article
  10. Region-Specific Regulation of Presynaptic Dopamine Homeostasis by DThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Article
  11. Amphetamine Reverses Escalated Cocaine Intake via Restoration of Dopamine Transporter Conformation.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 3 countries.

W Anthony OwensDepartment of Physiology and Pharmacology, The University of Texas Health Science Center, San Antonio, TX 78229, USA.
Jason M Williams
Christine Saunders
Malcolm J Avison
Aurelio Galli
Lynette C Daws
Center for Neurosciences · USThe University of Texas Health Science Center at San Antonio · US

Funding

Molecular Mechanisms of Stimulant AbuseR01DA014684 · NIDA · VANDERBILT UNIVERSITY · PI DAWS, LYNETTE C, GALLI, AURELIO · 2001 to 2010
$2.4M
AMPHETAMINE, INSULIN AND THE DA TRANSPORTER IN VIVOR21DA018992 · NIDA · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI DAWS, LYNETTE C · 2004 to 2005
$292k
NIH INTRAMURAL NRSA INSTITUTIONAL TRAINING PROGRAMF35DK008571 · NIDDK · U.S. NATIONAL INST DIABETES/DIGST/KIDNEY · PI BODNER, AMOS · 1990 to 1990
–
NIDA NIH HHS DA014684NIDA NIH HHS DA018992NIDA NIH HHS R01 DA014684NIDA NIH HHS R21 DA018992NIDDK NIH HHS DK08571
6 · The paper itself

Abstract

The dopamine (DA) transporter (DAT) is a major target for abused drugs and a key regulator of extracellular DA. A rapidly growing literature implicates insulin as an important regulator of DAT function. We showed previously that amphetamine (AMPH)-evoked DA release is markedly impaired in rats depleted of insulin with the diabetogenic agent streptozotocin (STZ). Similarly, functional magnetic resonance imaging experiments revealed that the blood oxygenation level-dependent signal following acute AMPH administration in STZ-treated rats is reduced. Here, we report that these deficits are restored by repeated, systemic administration of AMPH (1.78 mg/kg, every other day for 8 d). AMPH stimulates DA D(2) receptors indirectly by increasing extracellular DA. Supporting a role for D(2) receptors in mediating this "rescue," the effect was completely blocked by pre-treatment of STZ-treated rats with the D(2) receptor antagonist raclopride before systemic AMPH. D(2) receptors regulate DAT cell surface expression through ERK1/2 signaling. In ex vivo striatal preparations, repeated AMPH injections increased immunoreactivity of phosphorylated ERK1/2 (p-ERK1/2) in STZ-treated but not control rats. These data suggest that repeated exposure to AMPH can rescue, by activating D(2) receptors and p-ERK signaling, deficits in DAT function that result from hypoinsulinemia. Our data confirm the idea that disorders influencing insulin levels and/or signaling, such as diabetes and anorexia, can degrade DAT function and that insulin-independent pathways are present that may be exploited as potential therapeutic targets to restore normal DAT function.

Indexed as

AmphetamineAnalysis of VarianceAnimalsBlood GlucoseBody WeightBrainBrain MappingCorpus StriatumDiabetes Mellitus, ExperimentalDopamineDopamine AgentsDopamine Plasma Membrane Transport ProteinsDrug Administration ScheduleDrug InteractionsEnzyme InhibitorsHypoglycemic AgentsAmphetamineBlood GlucoseDopamineDopamine AgentsDopamine Plasma Membrane Transport ProteinsEnzyme InhibitorsHypoglycemic AgentsInsulinOxygenRacloprideReceptors, Dopamine D2

Identifiers

PMID22357848
PMCPMC3310897
OpenAlexW2145219348

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.